LUCIPAZO

About this medicine

Originator: Votrient by Novartis Pharmaceuticals · Manufacturer: Lucius Pharma. Indication & Dosage: LUCIPAZO (Pazopanib), generic Votrient is a prescription medicine used to treat of patients with advanced renal cell carcinoma (Kidney Cancer) and advanced soft tissue sarcoma (STS) who have received prior chemotherapy. Pazopanib works by decreasing the blood supply to the cancer tumor to slow tumor growth. LUCIPAZO manufactured by Lucius Pharma Ltd. In Laos. Pazopanib has to take 800 mg orally once daily without food on an empty stomach (at least 1 hour before or 2 hours after food). Side Effects: The most common adverse reactions of Pazopanib are: Diarrhea , nausea / vomiting , headache , loss of appetite , weight loss, altered sense of taste, numbness/ tingling/ redness in hands/ feet, or feeling tired/ weak, temporary hair loss and/or change in hair or skin color. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.